BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 26142466)

  • 1. Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes.
    Nanchen D; Gencer B; Auer R; Räber L; Stefanini GG; Klingenberg R; Schmied CM; Cornuz J; Muller O; Vogt P; Jüni P; Matter CM; Windecker S; Lüscher TF; Mach F; Rodondi N
    Eur Heart J; 2015 Sep; 36(36):2438-45. PubMed ID: 26142466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in the Polish tertiary centre: Results from the TERCET registry with 19,781 individuals.
    Dyrbuś K; Gąsior M; Desperak P; Osadnik T; Nowak J; Banach M
    Atherosclerosis; 2019 Sep; 288():33-41. PubMed ID: 31319356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.
    Amor-Salamanca A; Castillo S; Gonzalez-Vioque E; Dominguez F; Quintana L; Lluís-Ganella C; Escudier JM; Ortega J; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
    J Am Coll Cardiol; 2017 Oct; 70(14):1732-1740. PubMed ID: 28958330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, clinical features and prognosis of familial hypercholesterolemia in Chinese Han patients with acute coronary syndrome after a coronary event: a retrospective observational study.
    Kou H; Wang H; Liu P; Wang X; Zhu W; Jiang W; Hu X; Deng J
    BMC Cardiovasc Disord; 2024 Mar; 24(1):144. PubMed ID: 38443803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary Syndromes.
    Nanchen D; Gencer B; Muller O; Auer R; Aghlmandi S; Heg D; Klingenberg R; Räber L; Carballo D; Carballo S; Matter CM; Lüscher TF; Windecker S; Mach F; Rodondi N
    Circulation; 2016 Sep; 134(10):698-709. PubMed ID: 27462068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration into lipid management and persistent risk in patients hospitalised for acute coronary syndrome in Japan (EXPLORE-J): protocol for a prospective observational study.
    Nakamura M; Uno K; Hirayama A; Ako J; Nohara A; Arai H; Harada-Shiba M
    BMJ Open; 2017 Jul; 7(6):e014427. PubMed ID: 28674132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suboptimal consideration and management of potential familial hypercholesterolaemia in patients with suspected premature coronary artery disease.
    Yudi M; Omera L; McCubbery N; Dick S; Jayasinghe R; Hamilton-Craig I
    Singapore Med J; 2012 Mar; 53(3):174-8. PubMed ID: 22434290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of familial hypercholesterolemia on long-term outcomes in patients undergoing percutaneous coronary intervention.
    Tscharre M; Herman R; Rohla M; Piackova E; Vargas KG; Farhan S; Freynhofer MK; Weiss TW; Huber K
    J Clin Lipidol; 2019; 13(1):115-122. PubMed ID: 30344049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial Hypercholesterolemia Among Young Adults With Acute Coronary Syndrome.
    Haskiah F; Erez D; Khaskia A
    Am J Cardiol; 2023 Jan; 186():189-195. PubMed ID: 36270825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of heterozygous familial hypercholesterolaemia and its impact on long-term prognosis in patients with very early ST-segment elevation myocardial infarction in the era of statins.
    Rallidis LS; Triantafyllis AS; Tsirebolos G; Katsaras D; Rallidi M; Moutsatsou P; Lekakis J
    Atherosclerosis; 2016 Jun; 249():17-21. PubMed ID: 27062405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, management, and outcomes of familial hypercholesterolemia in patients with acute coronary syndromes in the Arabian Gulf.
    Al-Rasadi K; Al-Zakwani I; Alsheikh-Ali AA; Almahmeed W; Rashed W; Ridha M; Santos RD; Zubaid M
    J Clin Lipidol; 2018; 12(3):685-692.e2. PubMed ID: 29574074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of familial hypercholesterolaemia in patients presenting with premature acute coronary syndrome.
    Hauguel-Moreau M; Aïdan V; Hergault H; Beauchet A; Pépin M; Prati G; Pillière R; Ouadahi M; Josseran L; Rodon C; Rabès JP; Charron P; Dubourg O; Massy Z; Mansencal N
    Arch Cardiovasc Dis; 2022 Feb; 115(2):87-95. PubMed ID: 35123917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying familial hypercholesterolemia in acute coronary syndrome.
    Gencer B; Nanchen D
    Curr Opin Lipidol; 2016 Aug; 27(4):375-81. PubMed ID: 27092769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of clinical familial hypercholesterolaemia among patients with high cholesterol levels.
    Martinsen MH; Hedegaard BS; Klausen IC; Mortensen MB
    Dan Med J; 2019 Nov; 66(11):. PubMed ID: 31686647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond early LDL cholesterol lowering to prevent coronary atherosclerosis in familial hypercholesterolaemia.
    Ibrahim S; Reeskamp LF; de Goeij JN; Hovingh GK; Planken RN; Bax WA; Min JK; Earls JP; Knaapen P; Wiegman A; Stroes ESG; Nurmohamed NS
    Eur J Prev Cardiol; 2024 May; 31(7):892-900. PubMed ID: 38243822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial hypercholesterolemia among unselected contemporary patients presenting with first myocardial infarction: Prevalence, risk factor burden, and impact on age at presentation.
    Mortensen MB; Kulenovic I; Klausen IC; Falk E
    J Clin Lipidol; 2016; 10(5):1145-1152.e1. PubMed ID: 27678431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217.
    Benn M; Watts GF; Tybjærg-Hansen A; Nordestgaard BG
    Eur Heart J; 2016 May; 37(17):1384-94. PubMed ID: 26908947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales.
    Haralambos K; Whatley SD; Edwards R; Gingell R; Townsend D; Ashfield-Watt P; Lansberg P; Datta DB; McDowell IF
    Atherosclerosis; 2015 May; 240(1):190-6. PubMed ID: 25797312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leucine 10 allelic variant in signal peptide of PCSK9 increases the LDL cholesterol-lowering effect of statins in patients with familial hypercholesterolaemia.
    Pisciotta L; Sallo R; Rabacchi C; Wunsch A; Calandra S; Bertolini S
    Nutr Metab Cardiovasc Dis; 2012 Oct; 22(10):831-5. PubMed ID: 21920719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prevalence and Diagnostic Ratio of Familial Hypercholesterolemia (FH) and Proportion of Acute Coronary Syndrome in Japanese FH Patients in a Healthcare Record Database Study.
    Teramoto T; Sawa T; Iimuro S; Inomata H; Koshimizu T; Sakakibara I; Hiramatsu K
    Cardiovasc Ther; 2020; 2020():5936748. PubMed ID: 32636924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.